Sign in
  Edit search
The tumour necrosis factor receptor superfamily member 1b 67…
The tumour necrosis factor receptor superfamily member 1b 676T%26gt%3BG polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.
The tumour necrosis factor receptor superfamily member 1b 676T%26gt%3BG polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.
Article, Chapter
Authors: E.J. Toonen
Publication: Annals of the Rheumatic Diseases, Volume:67, Issue:8, Page(s):1174
Published: BMJ Group, 2008
ISSN: 0003-4967
  Full text availability for this item
View Full Text Source:Annals of the Rheumatic Diseases,Annals of the Rheumatic Diseases,BMJ Journals All Titles Opens in new Window
Journal:  Annals of the Rheumatic Diseases Source:BMJ Journals All Titles Opens in new Window
Collection:  BMJ Journals All Titles Opens in new Window
Coverage:
  • 1939~present; volume:1~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item